Clinitek Microalbumin 9 reagent strips for the early detection and monitoring of kidney disease

Publication date:

Clinitek Microalbumin 9 reagent strips for the early detection and monitoring of kidney disease
 
Status
In progress
Publication date
TBC
Notification date
January 2012

Provisional Schedule

Submission Date: TBC
Topic Selection: TBC
Draft guidance meeting TBC
Consultation opens: TBC
Consultation ends: TBC
Final guidance meeting: TBC

Project Team

Patient Involvement Lead: Laura Norburn
Analyst: TBC
Communications Lead: Tonya Gillis
Project manager:

Marlon Hope

Implementation Lead: Katie Worrall

Stakeholders

  • NICE is developing guidance on this technology. If you would like to become a registered stakeholder in the development of guidance on this technology, please complete a stakeholder registration and confidentiality form (Word), and return to us at medtech@nice.org.uk.

    Registered stakeholders will be informed of key stages in the development of guidance including when documents go out to consultation or comment.

Timeline

Date
Update
6 December 2012
The National Institute for Health and Clinical Excellence (NICE) is evaluating this technology. For further details on the process please see the Process and Methods Guides.
Get involved